文献速递肾小球疾病

局灶节段性肾小球硬化亚分类在IgA肾病中的临床意义

Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该研究回顾性纳入746例IgA肾病患者,采用卡方自动交互检测法识别与蛋白尿、eGFR和主要不良肾脏事件(MAKE)相关的S病变亚组,并用Cox回归和倾向性评分分析预后及免疫抑制治疗的效果。结果显示S1病变占80%,其中NOS+Adh+亚组预后最差,但免疫抑制治疗与该亚组更好的结局相关,且收缩压>130 mmHg显著影响该亚组对MAKE的影响。

要点

  • S1病变见于80%的IgA肾病患者,NOS、Adh和PH为前三位亚型。
  • S1伴NOS+Adh+亚组患者蛋白尿和肾功能损伤更重,总体肾脏预后显著更差。
  • 免疫抑制治疗与S1伴NOS+Adh+亚组更好的结局相关;收缩压>130 mmHg显著增加该亚组MAKE风险。

核心结论

  • 本研究在亚洲人群中验证了IgA肾病S亚分类的临床价值。
  • NOS+Adh+病变患者蛋白尿和肾功能损伤更严重,总体肾脏预后显著更差,但可从肾素-血管紧张素系统抑制剂联合免疫抑制剂的治疗策略中获益。
  • 将收缩压控制在130 mmHg以下似乎是合适的范围。

研究设计与样本

  • 回顾性纳入746例IgA肾病患者。
  • 采用卡方自动交互检测法识别与蛋白尿、eGFR和主要不良肾脏事件(MAKE)相关的S病变亚组。
  • 采用Kaplan-Meier分析评估MAKE差异,Cox比例风险回归模型估计S1病变对MAKE的风险比,倾向性评分分析评估免疫抑制治疗与亚组结局的关联。

主要发现

  • 746例患者中S1病变占80%,前三位亚型为节段性毛细血管壁基质闭塞(NOS,69%)、无毛细血管闭塞的单纯囊壁粘连(Adh,63%)和足细胞肥大(PH,16%)。
  • 三种病变类型均与蛋白尿相关,NOS还与eGFR相关。
  • S1伴NOS+Adh+亚组患者预后最差。
  • 免疫抑制治疗与S1伴NOS+Adh+患者更好的结局相关。
  • 亚组分析显示NOS+Adh+病变对MAKE的影响显著受收缩压影响,NOS+Adh+病变且收缩压>130 mmHg的患者MAKE风险显著增加。

临床怎么用

  • 作者认为,对于S1伴NOS+Adh+病变的IgA肾病患者,采用肾素-血管紧张素系统抑制剂联合免疫抑制剂的治疗策略可使其获益。
  • 作者认为,将收缩压控制在130 mmHg以下似乎是合适的范围。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: Evidence from the VALIGA Immunoglobulin A (IgA) nephropathy (IgAN) cohort supports the clinical value of subclassifying focal segmental glomerulosclerosis lesions (S). Our study aimed to validate and explore the clinical significance of S subclassification in an Asian population. METHODS: A total of 746 patients with IgAN were retrospectively included. The chi-squared automatic interaction detection method was used to identify subgroups of S lesions associated with proteinuria, eGFR, and major adverse kidney events (MAKE). Kaplan-Meier analysis was performed to assess differences in MAKE. Hazard ratios for S1 lesions with respect to MAKE were estimated using Cox proportional hazards regression models. Propensity score analysis was used to evaluate whether immunosuppressive therapy was associated with a favorable outcome within subgroups. RESULTS: Among 746 patients, S1 lesions were present in 80% of individuals, with segmental capillary occlusion by matrix (not otherwise specified (NOS), 69%), simple capsular adhesion without capillary occlusion (Adh, 63%), and podocyte hypertrophy (PH, 16%) being the top three subtypes. All three lesion types were associated with proteinuria, and NOS was also correlated with eGFR. Patients in the S1 with NOS+Adh+ subgroup had the worst prognosis. Moreover, immunosuppressive therapy was associated with better outcomes in S1 patients with NOS+Adh+. Subgroup analysis showed that the effect of NOS+Adh+ lesions on MAKE was significantly influenced by systolic blood pressure (SBP). Patients with NOS+Adh+ lesions and SBP >130 mmHg had a significantly increased risk of MAKE. CONCLUSION: Our study validated the clinical value of S subclassification in IgAN in an Asian population. Patients with NOS+Adh+ lesions have more severe proteinuria and renal function damage. Their overall renal prognosis is significantly worse; however, they can benefit from a treatment strategy that combines renin-angiotensin system inhibitors with immunosuppressants. In addition, controlling SBP to below 130 mmHg seems to be an appropriate range.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lu F, Hou S, Liu C, et al. Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy. Nephrol Dial Transplant. 2026. PMID: 40824629. doi:10.1093/ndt/gfaf162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。